Business Wire

Advantage Smollan Acquires Integrated Creative Agency Intermarketing

5.6.2017 18:00 | Business Wire

Jaa

Advantage Smollan, the joint holding company between Advantage Solutions (Advantage) and Global Smollan Holdings (Smollan), announced today its acquisition of Intermarketing Agency (Intermarketing), an award-winning, integrated creative agency based in London, Leeds, Amsterdam, and Sydney.

Advantage Smollan provides outsourced sales, marketing, and technology solutions for consumer goods manufacturers and retailers in a number of European markets. Intermarketing extends Advantage Smollan’s capabilities into several areas including brand and retail campaigns, strategy, brand communications, data and insights, and content creation.

Laurence Clube, COO of Advantage Smollan, commented, “This move is hugely significant for us as we continue to broaden our range of services. It’s great to have a business of the quality of Intermarketing joining us.”

“Our expansion efforts are both geographic and capability-oriented” said Tanya Domier, CEO of Advantage. “Intermarketing’s focus across consumer, shopper, and experiential marketing is similar to the service mix we have built our reputation around in the U.S. Bringing them on board strengthens our value proposition in Europe as well as our ability to service clients globally.”

David Smollan, CEO of Smollan, added, "We are very excited about the addition of Intermarketing to the Advantage Smollan portfolio. They are a great cultural fit for our group and bring great expertise through their diversified service offerings."

Intermarketing, with over 170 members of staff, was founded in 1988 and holds an impressive client portfolio including brands from the worlds of sports, finance, and fashion.

“We’re excited for the future of Intermarketing Agency and for all the people we employ.” said joint Managing Partners Steve Sowden and Jamie Allan.

“The agency has seen rapid growth since 2011 and being part of the Advantage Smollan group will help move the agency to the next level. It was very important for us to find a parent company that had a shared vision, culture, and mindset when it came to business and we believe we have found exactly that.”

“As part of the wider group we can continue to grow both our geographical reach and our skill base whilst supporting Advantage Smollan’s own plans for expansion.”

About Advantage Smollan

Founded in 2015, Advantage Smollan is a jointly-owned holding company of Advantage Solutions (Advantage) and Global Smollan Holdings (Smollan) that provides unified sales, marketing, and technology solutions for consumer goods manufacturers and retailers across Europe. Advantage Smollan offers the industry’s best capabilities and technology along with the local knowledge to address the unique dynamics of individual markets. The company combines Advantage’s and Smollan’s best practices and resources with the extensive experience and market leadership of each portfolio company – all aligned in service excellence, thought leadership, and entrepreneurial spirit to deliver better results for clients and customers. For more information, visit www.advantagesmollan.com. For more information on Advantage, visit www.advantagesolutions.net. For more information on Smollan, visit www.smollan.com.

About Intermarketing Agency

Intermarketing is an integrated, creatively-driven and service-led agency with a focus on ROI. With 29 years of brand building expertise Intermarketing has the ability to execute campaign ideas globally across all channels, building specialist teams around client requirements to offer true collaboration and expertise in brand communications, data and CRM, digital, experiential, retail, TV and video, 3D and animation, media, partnerships, content, and social media. For additional information visit www.intermarketing.com

Contact information

Advantage Solutions
Will Minton, VP Corporate Marketing
Tel: 949 797 3105
Email: will.minton@advantagesolutions.net
or
Bryce Robinson, General Counsel
Tel: 949 794 2204
Email: bryce.robinson@advantagesolutions.net
or
Intermarketing Agency
Steve Sowden, Managing Partner
Tel: +44 (0)113 275 3912
Email: steve.sowden@intermarketing.com
or
Jamie Allan, Managing Partner
Tel: +44 (0)113 275 3912
Email: jamie.allan@intermarketing.com
or
Smollan
Monique Yaffe, Chief Marketing Officer
Tel: +27 11 458 0000
Email: monique.yaffe@smollan.com
or
Advantage Smollan
Laurence Clube, COO Advantage Smollan
Tel: +44 (0)118 927 1010
Email: lclube@advantagesmollan.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

IFF to Present at the Barclays Global Consumer Staples Conference21.8.2017 23:15Tiedote

Regulatory News: International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris:IFF), a leading innovator of sensory experiences that move the world, today announced that Andreas Fibig, Chairman and Chief Executive Officer will present at the Barclays Global Consumer Staples Conference in Boston, MA on Thursday, September 7, 2017 at 11:15 a.m. EDT. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Meet IFF International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris:IFF) is a leading innovator of sensorial experiences that move the world. At the heart of our company, we are fueled by a sense of discovery, constantly asking “what if?”. That passion for explorati

Celularity, Inc., Accelerates Breakthrough Placental Discovery & Therapeutic Platform21.8.2017 23:11Tiedote

Celularity, Inc., a newly formed biotechnology company, today announced its acceleration of cell and tissue regenerative therapies to address unmet medical needs in cancer and chronic and degenerative disease. Celularity completed their Series A financing with contributions from several biopharma companies, including Sorrento Therapeutics, United Therapeutics Corporation and Human Longevity, Inc., and entrepreneurial investors. Celularity has been created through the contributions of extensive intellectual property, clinical-stage assets, basic and clinical research, and development expertise including: Several clinical-stage immuno-oncology and regenerative medicine assets and a pipeline of pre-clinical assets Proprietary allogeneic (“readily accessible”) immunotherapy platform 200+ issued and pending patents in cell therapy

European Commission Grants New Indication for Soliris® (Eculizumab) for the Treatment of Patients with Refractory Generalized Myasthenia Gravis (gMG)21.8.2017 16:25Tiedote

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that the European Commission (EC) approved the extension of the indication for Soliris® (eculizumab) to include the treatment of refractory generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor (AChR) antibody-positive. Soliris is the first and only complement-based therapy approved in the European Union (EU) for this ultra-rare subset of patients.1-4 Patients with refractory gMG can have difficulties walking, talking, swallowing and breathing normally despite therapies currently used for MG. Exacerbations and crises of their disease may require hospitalization and intensive care and may be life-threatening.5-7 Soliris will be launched for this new indication initially in Germany, and Alexion is evaluating launches in additional EU countries. “Patients with refractory gMG have exhausted multiple the

IntegenX Applauds the Passage of the Rapid DNA Act of 201721.8.2017 15:00Tiedote

IntegenX Inc., the global market leader for Rapid DNA human identification, applauds the signing into law of S.139 and HR.510, The Rapid DNA Act of 2017. The legislation will allow law enforcement agencies, under standards and guidelines established by the FBI, to perform real-time DNA testing at time of arrest, within booking stations. Similar to how fingerprint analysis has evolved from a paper and ink practice to a point-of-action technology, DNA testing has now become possible in 90 minutes within a booking station, while a suspect is still in custody. With processing times reduced from weeks to less than two hours, the potential to identify or exonerate a suspect quickly will make a meaningful impact on law enforcement. IntegenX thanks U.S. Senate sponsor Senator Orrin Hatch (R-UT) and lead co-sponsor Senator Dianne Feinstein (D-CA) as well as House sponsor Congressman

PPG Completes COLORFUL COMMUNITIES Project at Primary School in Kecskemét, Hungary21.8.2017 11:03Tiedote

PPG (NYSE:PPG) today announced the completion of a COLORFUL COMMUNITIES™ project in Kecskemét, Hungary, that helped revitalize the learning environment of the Corvin Mátyás primary school. The Colorful Communities program provides PPG volunteers and products along with financial contributions to bring color and vitality to communities where the company operates around the world, such as in Kecskemét, where the PPG automotive service team operates with 33 employees. The project brought together more than 140 PPG and community volunteers who spent three days at the school revitalizing four classrooms, four changing rooms and the playground. PPG provided more than $20,000 to assist with the project, including more than 460 liters of Héra ® Prémium waterborne interior paint and Trinát ® Aqua wate

Glennmont Partners Completes Refinancing of Sleaford Biomass Plant for £150m21.8.2017 11:00Tiedote

Glennmont Partners has successfully completed the refinancing of the Sleaford Renewable Energy Plant on behalf of its dedicated clean energy fund, Glennmont Clean Energy Fund Europe I, as part of a programme of realisations of value from the Fund. Glennmont Partners is one of Europe’s largest fund managers focusing exclusively on investment in clean energy infrastructure. Glennmont raises long-term capital to invest in alternative power generation projects including wind farms, biomass power stations, solar parks and small-scale hydro power plants. The carefully selected, risk managed investments deliver sustained performance and predictable returns over periods of 10 years or more. Sleaford REP is a 40MWe straw-fired biomass plant located in Lincolnshire, UK. The plant has been in operation since 2014 and is being operated by Burmeister & Wain Scandinavian Contractor (BWSC). The

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme